Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
MapLight Therapeutics
Age
12–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 12 to 45 at screening
Has a designated care/study partner who can reliably report on symptoms
Has a diagnosis of Autism Spectrum Disorder (ASD)
Has a body mass index (BMI) 18 through 34 kg/m², inclusive
Full scale IQ (or equivalent) ≥55 score, with adequate verbal fluency, as determined by the Principal Investigator.
Psychoactive medications and adjunctive therapies are stable for 4 weeks prior to screening
Must be able to swallow study medication
You may not be if
Has Rett syndrome or Child Disintegrative Disorder
Has participated in any other study and received any other investigational medication (other than COVID-19 vaccination) or device within 60 days prior to screening
History of epilepsy without current adequate control, or any seizure in the 6 months preceding screening
History of suicidal ideation or behavior in the past 12 months, or a positive response to C-SSRS questions 4 and/or 5
Systolic blood pressure ≥140 mmHg (if adult) or \>135 mmHg (if adolescent), or diastolic blood pressure ≥90 (if adult) or \>85 mmHg (if adolescent), or a clinical history of uncontrolled or severe hypertension
